Pentagon funds vaccine to counter airborne exposure to Ebola

DoD considers Ebola spreading through air a severe threat

By Kit Daniels | Infowars.com

Citing concerns over “aerosol exposure to Ebola,” the Pentagon awarded a $9.5 million contract to a biotechnology company to manufacture an Ebola vaccine.

The company, Profectus BioSciences, announced today that the Pentagon “contracted the manufacture and … preclinical testing of the Profectus trivalent Ebola/Marburg vaccine” which had previously been tested to “confirm protection of non-human primates from aerosol exposure to Ebola and Marburg viruses.”

“In July 2014, Profectus BioSciences and the GNL were awarded a 3 year, $8.5M grant from the DOD/Joint Vaccine Acquisition Program to support development of a lyophilized trivalent VesiculoVax™-vectored vaccine to protect against all major strains of Ebola and Marburg viruses delivered as aerosols,” the press release stated. “The lyophilized trivalent vaccine is being tested in both pre-exposure and post-exposure studies to confirm protection of non-human primates from aerosol exposure to Ebola and Marburg viruses.”

Read Full Article